机译:囊性纤维化转换从单组合Elexacafer / Tezacaftor / Ivacafacter / Ivacafacter / Ivacafacter / Ivacafacter / Ivacafacter患者CFTR调制的生理基础药代动力学建模
CFTR modulator; Cystic fibrosis; Elexacaftor; Ivacaftor; Lumacaftor; Physiologically based pharmacokinetic modeling; Tezacaftor; Transition modeling; Triple combination;
机译:囊性纤维化转换从单组合Elexacafer / Tezacaftor / Ivacafacter / Ivacafacter / Ivacafacter / Ivacafacter / Ivacafacter患者CFTR调制的生理基础药代动力学建模
机译:Elexacaftor Plus Tezacaftor Plus invacafactor组合方案对F508del突变的囊性纤维化纯合的疗效和安全性:双盲,随机,第3阶段试验(Vol 394,PG 1940,2019)
机译:Elexacafactor Plus Tezacaftor的功效和安全性Plus Ivacaftor组合中的人们在囊性纤维化纯合的F508del突变中:双盲,随机,第3阶段试验
机译:患者个体化生理学药代动力学建模的PSE方法
机译:Elexacaftor-Tezacaftor-Ivacaftor:首个三联囊性纤维化跨膜电导调节剂调节疗法
机译:囊性纤维化转换从单组合Elexacafer / Tezacaftor / Ivacafacter / Ivacafacter / Ivacafacter / Ivacafacter / Ivacafacter患者CFTR调制的生理基础药代动力学建模